Pfizer Inc. (PFE)

Statement of Comprehensive Income

Beginner level

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Pfizer Inc., consolidated statement of comprehensive income

US$ in millions

12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Net income before allocation to noncontrolling interests	11,188	21,355	7,246	6,986	9,168
Foreign currency translation adjustments	(915)	1,493	(800)	(3,200)	(2,096)
Derivative financial instruments	197	(378)	(73)	(96)	438
Available-for-sale securities	(469)	532	96	(5)	(372)
Actuarial gains (losses)	(765)	211	(740)	921	(2,432)
Prior service (costs) credits and other	(22)	(128)	(1)	148	420
Benefit plans	(787)	83	(741)	1,069	(2,012)
Other comprehensive income (loss) before allocation to noncontrolling interests	(1,974)	1,730	(1,518)	(2,232)	(4,042)
Comprehensive income before allocation to noncontrolling interests	9,214	23,085	5,728	4,754	5,126
Comprehensive (income) loss attributable to noncontrolling interests	(16)	(62)	(27)	1	(36)
Comprehensive income attributable to Pfizer Inc.	9,198	23,023	5,701	4,755	5,090

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Comprehensive income item	Description	The company
Net income attributable to Pfizer Inc.	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Pfizer Inc.’s net income attributable to Pfizer Inc. increased from 2016 to 2017 but then slightly decreased from 2017 to 2018 not reaching 2016 level.
Comprehensive income attributable to Pfizer Inc.	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.	Pfizer Inc.’s comprehensive income attributable to Pfizer Inc. increased from 2016 to 2017 but then slightly decreased from 2017 to 2018 not reaching 2016 level.